Natural history of a randomized trial comparing distal spleno-renal shunt with endoscopic sclerotherapy in the prevention of variceal rebleeding: A lesson from the past

Figure 1 Reasons for exclusion. pts: patients.

Figure 2 Actuarial curves of patients free from gastroesophageal rebleeding after distal spleno-renal shunt (DSRS) and endoscopic sclerotherapy (ES). P < 0.05 vs ES using the log-rank test.

Figure 3 Actuarial survival curves for distal spleno-renal shunt (DSRS) and endoscopic sclerotherapy (ES). DSRS vs ES for the first 5 years (breslow test P = 0.038) while no differences were found in the final outcome (log rank test P = 0.1168)